Abstract
Background
Mosquito-borne viral infections have in recent years, become a public health threat globally. This review aimed to provide an overview of the ecological and epidemiological profiles of mosquito-borne viral infections in the Democratic Republic of the Congo (DRC).
Methods
A search of literature was conducted using Google Scholar, PubMed and the WHO website using the following keywords: “Democratic Republic of the Congo”, “Zaire”, “Belgian Congo” and either of the following: “mosquito-borne virus”, “arbovirus”, “yellow fever”, “dengue”, “chikungunya”, “West Nile”, “Rift Valley fever”, “O’nyong’nyong”, “Zika”, “epidemiology”, “ecology”, “morbidity”, “mortality”. Published articles in English or French covering a period between 1912 and October 2018 were reviewed.
Results
A total of 37 articles were included in the review. The findings indicate that the burden of mosquito-borne viral infections in DRC is increasing over time and space. The north-western, north-eastern, western and central regions have the highest burden of mosquito-borne viral infections compared to south and eastern highland regions. Yellow fever, chikungunya, dengue, Zika, Rift Valley fever, West Nile and O’nyong’nyong have been reported in the country. These mosquito-borne viruses were found circulating in human, wildlife and domestic animals. Yellow fever and chikungunya outbreaks have been frequently reported. Aedes aegypti and Ae. simpsoni were documented as the main vectors of most of the mosquito-borne viral infections. Heavy rains, human movements, forest encroachment and deforestation were identified as drivers of mosquito-borne viruses occurrence in DRC.
Conclusions
Mosquito-borne viral infections are becoming common and a serious public health problem in DRC. In the current context of climate change, there is urgent need to improve understanding on ecological and epidemiology of the diseases and strengthen surveillance systems for prompt response to epidemics in DRC.
Keywords: Mosquito-borne viruses, Epidemiology, Ecology, Democratic Republic of the Congo
Background
Arthropod-borne viruses are referred to as viruses transmitted either to animals or humans by blood-sucking arthropods [1]. There are over 700 known arthropod-borne viruses and at least 80 immunologically distinct types that cause diseases in humans [2]. Most of the arthropod-borne viral infections are transmitted by mosquitoes. Transmission of these viruses to humans involves complex processes influenced by the mosquito and viral genetics, environmental factors and human activities [3]. Mosquitoes belonging to the genus Aedes are the major vectors of Chikungunya (CHIKV), Dengue (DENV), Rift Valley fever (RVFV), Yellow fever (YFV) and Zika (ZIKV) [4]. These mosquito-borne viral diseases are often misdiagnosed with other febrile illnesses, such as malaria due to lack of differential diagnostic tools [5]. The geographical distribution patterns of these mosquito-borne viruses are related to the presence of their mosquito vectors; and overlap as they share common vectors. Therefore, co-infection or co-occurrence of more than one mosquito-borne virus species in a certain geographical location is common [6].
The Democratic Republic of the Congo (DRC) is located in central Africa. It is the second largest and one of the most populated countries in Africa. The DRC harbours rich fauna, flora and biodiversity which offer suitable opportunity for the emergence of numerous viral diseases. A number of mosquito-borne virus species have been documented in some regions of DRC during the last century. The first yellow fever outbreak in DRC was reported from Kongo-Central in 1912 [7]. Thereafter a number of studies on YFV and other mosquito-borne viral infections were carried out and extended to other geographical locations until the end of colonial period in 1960 [8]. During the past two decades, repeated outbreaks of Chikungunya and Yellow fever have been reported in DRC. During the same time, the circulation of other mosquito-borne viruses of public health importance such as DENV, ZIKV, RVFV and West Nile virus (WNV) have also been recorded [9–11]. This review attempts to summarize the available data on mosquito-borne viral infections in DRC in order to provide an insight of their geographical distribution, virus species diversity, mosquito vectors and animal reservoirs. In addition, the review explores the risks factors associated with their transmission and epidemic occurrence.
Methods
Search strategy
Using PRISMA guidelines for systematic review, a literature search was carried out using Google Scholar and PubMed databases to find relevant information related to ecology and epidemiology of mosquito-borne viral infections in the DRC. Combinations of search keywords were used (“Belgian Congo” OR “Democratic Republic of the Congo” OR “Zaïre”) AND (“mosquito-borne virus” OR arbovirus OR “arthropod-borne virus” OR “yellow fever” OR “chikungunya” OR “dengue” OR “Rift Valley Fever virus” OR “West Nile virus” OR “Zika” OR “alphavirus” OR “flavivirus” OR “bunyavirus”). Additional information was searched from the World Health Organization (WHO) (http://www.who.int) database. Articles in either English or French were included in the review. Initially, titles and abstracts were screened, then full text of articles identified as possibly relevant were reviewed. The bibliographies of included articles were assessed for further relevant publications. In case of duplicated articles, only one was considered in this study (Fig. 1).
Eligibility and inclusion criteria
The focus was on the articles that described mosquito-borne viruses in DRC between 1912 and October 2018. The information extracted from the reviewed articles included studies on the epidemiology and ecology of arboviruses including geographical location, study population, diagnostic method used, virus species detected, serotypes and genetic diversity, number of cases or prevalence, risk factors of transmission, mosquito vector and their habitats, potential host or reservoir, seasonality, epidemics/outbreaks, mortality and control options.
Exclusion criteria
Abstracts without available full text, articles in language other than English or French, review article duplicated information, studies describing only diagnostic methods or vaccine development were excluded.
Analysis
The results were described using figures to show the trends of distribution of mosquito-borne viruses occurrence over time and space. To map geographical distribution of mosquito-borne viruses in the DRC, geographical coordinates of study areas recorded in the present review were searched in the database of the Central African Satellite Forest Observatory (OSFAC), Kinshasa, DRC and associated with the respective mosquito-borne virus presence recoded. It was possible to obtain some precise details regarding the geographical areas of the reviewed articles by emailing authors directly. The maps were drawn using QGIS 2.2.0. (QGIS Development team, GNU General Public License).
Results
A total of 69 articles were retrieved and 37 articles covering a period between 1912 and October 2018 were included in the present review. Seven mosquito-borne viruses belonging to three families, the Flaviviridae, Bunyaviridae and Alphaviridae, were recorded across the DRC. Among the Flaviviridae, four species, YFV, DENV, ZIKV and WNV, were recorded. Among the Alphaviridae, two species, CHIKV and ONNV were reported. The recorded mosquito-borne viruses occurred either during an outbreak investigation, immediately after an outbreak, or occasionally during inter-epidemic periods. Most of the records were related to YFV and CHIKV. A number of studies were carried during colonial era before 1960 and around the beginning of the country’s independence in 1960. Most of the reports on mosquito-borne diseases were published between 1998 and 2018 (Fig. 2). Only two recent entomological studies were recorded in DRC, one study on Aedes fauna in Kinshasa [12] and another one on mosquito virus infectivity [13].
These viruses were identified using different diagnostic methods ranging from serological investigation [animal inoculation, enzyme‐linked immunosorbent assay (ELISA), western blot, plaque reduction neutralization test (PRNT)], morphological investigation of affected organs, tissue culture cell lines (Vero, C6/36) and molecular biological methods including reverse transcription polymerase chain reaction (RT-PCR) detection, genome sequencing and molecular genetics analysis. The majority of sample specimens analysed were from humans; few were from animals and mosquitoes. Some studies reported co-occurrence or co-infections of mosquito-borne viruses. These included CHIKV and YFV, CHIKV and DENV, YFV and DENV [9, 10, 14–16].
Yellow fever virus
The first yellow fever outbreak in DRC was reported among ship passengers from Europe in 1912 at Matadi Beach [7]. Later in 1928, another YFV outbreak occurred in the same area. This was the first autochthonous YFV outbreak in the DRC and it caused a mortality rate as high as 63.4% [17]. From 1948 to 1957, yellow fever cases were regularly recorded in DRC. In 1958, the country experienced two major outbreaks: first in Gemena township of the Sud-Ubangi Province (case fatality rate of 36.5%) [18] and another outbreak (co-infection with chikungunya) in the Territory of Dungu from Haut-Uelé Province [14]. Afterwards, in 1960, another yellow fever outbreak was reported from Bili village in Bondo territory of Bas-Uélé Province [15]. After the independence in 1960, yellow fever outbreaks kept on recurring in all 26 provinces of DRC. From 2001 to 2004, a nationwide surveillance reported about 400 yellow fever suspected cases annually without a biological confirmation and a lethality rate of 3% in 2004 [10]. In a demographic survey of 2013–2014, an overall YFV prevalence of 31.5% among children was reported in DRC [9]. Despite the implementation of a yellow fever vaccination programme (involving children 9 months-old) in DRC since 2003, most vaccinated children failed to demonstrate sufficient proof of seroconversion [9]. From 2010–2016, four yellow fever outbreaks resulting from either autochthonous or imported infections were reported in DRC [19–22]. The 2016 outbreak was the largest with causing a total of 393 deaths. While, initially the majority of recorded yellow fever cases were imported from neighbouring Angola, 90% of deaths in 2016 were recorded in a single Province of Kongo-Centrale [23]. The autochthonous cases of YFV have also been documented in the provinces of Bas-Uele, Equateur, Kasai-Central, Kinshasa, Kwango, Lualaba, Tshuapa and Kongo-Central [22] (Table 1).
Table 1.
Province (specific area) | No. of cases | No. of deaths | Period of record | References |
---|---|---|---|---|
Kongo-central (Matadi) | 6 | 1917 | [7] | |
Kongo-central (Matadi, Boma) | 41 | 26 | 1928 | [17] |
Haut-Uelé (Dungu) | 1958 | [14] | ||
Sud-Ubangi (Gemena) | 60 | 23 | 1958 | [18] |
Bas-Uélé (Bili village from Bondo) | 1961 | [15] | ||
Bas-Uélé (Titule Health Zone) | 11 | 2 | 2010 | [19] |
Lomami (Lubao Health Zone) Kasai-Orientale (KamanaLudimbi-Lukula Health Zone) | 51 | 19 | 2013 | [20] |
Bas-Uélé (Bondo, Buta), Haut-Lomami (Kikondja) | 139 | 6 | 2014 | [21] |
Kinshasa, Kongo-central, Bas-Uele, Equateur, Kasai-central, Kwango, Lualaba, Tshuapa | 2987 | 121 | 2016 | [22] |
Kongo-central (Nsonapangu, Kimpese, Kimpangu, Matadi, Moanda, Boma, Kitona, Masa) | 393 | 42 | 2016 | [23] |
The Democratic Republic of the Congo belongs to an endemic geographical area at high risk for YFV transmission [24]. YFV transmission in DRC varies from one region to another and within the region. The absence of YFV circulation or lowest seroprevalence (< 5%) has been observed from the provinces located in high altitudes covering the whole eastern region (Ituri, Sud-Kivu, Nord-Kivu, Maniema) and the southern region from former Katanga province (currently divided into Tanganyika, Haut-Lomami, Haut-Katanga, Lualaba) [25]. The highest seroprevalence of YFV (≥ 30%) has been recorded from the savannah regions intersected by forest galleries from northern regions and the Atlantic coastal region in western part of DRC [25, 26]. The identified territories with high YFV transmission were Bosobolo and Mobayi-mbongo in the Province of Nord-Ubangi in the North-West, Ango and Bondo in the Province Bas-Uélé in the North-East region and in the Province of Kongo-Central in western DRC [25]. Lower seroprevalence rates (10–20%) have been reported along the Equator forest and in the central part of the country (Mai-Ndombe, Equateur, Kasai, Kasai-Central, Kasai-Oriental and Lomami provinces), as well as from provinces of Kwilu and Kwango in the western region [27] (Fig. 3).
Chikungunya
The two first reported chikungunya cases in the DRC occurred during a yellow fever outbreak in north-eastern region. The first was in 1958 in Haut-Uelé Province [14], and the second in 1960 in the neighbouring Province of Bas-Uélé in Bondo territory [15]. Since then, no circulation of CHIKV was documented in DRC until 1998 [11]. In 1998, of 45 patients sampled during an outbreak of WNV in Kisangani City in Tshopo Province of the north-eastern region, 28.8% patients were found positive for CHIKV immunoglobulin M (IgM) antibodies [11]. Kinshasa, the capital of DRC experienced three chikungunya outbreaks during 1999 and 2000, with an estimated 50,000 suspected cases [28]. These outbreaks occurred after heavy rains in the urban areas of Matete and Kingabwa municipalities. The third occurred in the sub-rural area of Ndaku-ya-Mpembe in the Kinkole municipality. More than half (57.9%) the samples tested positive for CHIKV IgM antibodies and nine strains were isolated in C6/36 cells [28]. Furthermore, another outbreak was recorded in 2012 from three new areas (Maluku, Mont-ngafula and Mbinza Meteo health zones) in Kinshasa [16]. Of 10 cases of chikungunya recorded among Belgian travellers between 2007 and 2012, six were from DRC [29]. In a retrospective countrywide surveillance study carried out between 2003 and 2011, of the 453 sera screened, two positive cases of CHIKV were detected by RT-PCR. One case was from Gemena in the Sud-Ubangi Province in north-western DRC and the other from the Province of Kwilu [10]. In a survey carried out in 2015, from 96 patients tested negative for malaria in Kinshasa, the seroprevalence of CHIKV was 9.6% and 5 samples were found positive for CHIKV by RT-PCR [30]. Based on a genetic study, the isolates of CHIKV that were found to circulate in DRC belonged to the Congo genotype which is closely related to the Central African Republic and Uganda isolates [31] (Table 2). African buffalo, chimpanzee and elephant from Haut-Uelé Province have been identified as potential hosts or reservoirs of CHIKV by detecting the presence of antibodies from these species (Table 3) [32, 33].
Table 2.
Province (specific area) | Laboratory test | No. of samples tested (% positive) | Period of record | References |
---|---|---|---|---|
Haut-Uelé (Dungu in Doruma) | Animal inoculation | 3 (100) | October-December 1958 | [14] |
Bas-Uelé (Bondo in Bili) | Animal inoculation | 36 (44.0) | Rainy season of 1960 | [15] |
Tshopo (Kisangani) | ELISA (IgM) | 45 (28.8) | February-March 1998 | [11] |
Kinshasa: Matete (Des Marais), Kingabwa (Bribano), Kinkole (NdakuyaPembe) | ELISA IgM, Cell C6/36 | 76 (57.8) | February-May 1999; May-July 2000 | [28] |
Whole country | RT-PCR | 453 (0.4) | 2003–2012 | [10] |
Sud-Ubangi (Gemena), Kwilu | RT-PCR | 110 (1.8)) | 2003–2012 | [10] |
DRC/Belgium | RT-PCR, ELISA | 2012 | [29] | |
Kinshasa (Binza-Meteo, Mont-Ngafula, Maluku) | ELISA | 2012 | [16] | |
Kinshasa | RT-PCR, ELISA | 10 (9.6) IgM; 5 (4.8) in RT-PCR | 2014 | [30] |
Table 3.
Animal/mosquito | CHIKV | DENV | YFV | RVFV | WNV | ONNV | Alphavirus | Flavivirus | Study location |
---|---|---|---|---|---|---|---|---|---|
Chimpanzee | + | + | + | + | Haut-uelé (Ango, Bondo) [32] | ||||
Elephant | + | + | + | + | Garamba National Park [33] | ||||
Buffalo | + | + | + | + | + | + | Garamba National Park [33] | ||
Duiker | + | + | + | Ituri Rain Forest [33] | |||||
Gorillas | + | + | Virunga, Garamba National Park [33] | ||||||
Cattle | + | Katanga, Nord Kivu (Beni, Lubero, Butembo, Masisi, Rutshuru) Sud Kivu (Kabare, Mwenga, Shabunda) Ituri (Aru, Mahagi) [34, 35] | |||||||
Dog | + | Kinshasa [39] | |||||||
Horse | + | Kinshasa [38] | |||||||
Aedes spp. | + | + | + | + | Kinshasa [13] | ||||
Anopheles spp. | + | Kinshasa [13] | |||||||
Culex spp. | + | Kinshasa [13] |
Key: +, screened positive for virus
Dengue
Three serotypes of dengue virus (DENV-1, DENV-2 and DENV-3) have been recorded in DRC, the most frequent being serotype DENV-1 [9, 10, 30]. The first case of dengue was reported from Ango and Bongo territories from the Province of Haut-Uelé, where a dengue seroprevalence of 68.8% was reported in 1960 [32]. The prevalence in four studies carried out between 1998 and 2015 using different diagnostics methods (ELISA, PRNT, rapid diagnostic test and RT-PCR) ranged from 2.7% to 8.8% [9, 11, 30]. In Kisangani of Tshopo Province, DENV was reported to co-circulate with CHIKV during the West Nile outbreak of 1998 [11]. In Kinshasa, co-occurrence of dengue and chikungunya was reported during the outbreak of 2012 [16]. Dengue occurrence has been reported from western (Kinshasa, Kongo central), central (provinces of Kasai, Kasai Oriental), north-western (Equateur, Mongala, Sud Ubangi, Nord Ubangi) and north-eastern regions (Tshopo, Haut-uélé, Bas-Uélé) (Table 4). Antibodies against DENV have also been reported from chimpanzee in 1960 and from buffalo in 2013 [32, 33].
Table 4.
Province (specific areas) | Laboratory test | No. of samples tested (% positive) | Period of record | References |
---|---|---|---|---|
Haut-Uelé, Bas-Uéle (Ango-Bondo) | Animal inoculation | 32 (68.7); DENV-2 (95.0); DENV-1 (5.0) | October–December 1960 | [32] |
Tshopo (Kisangani) | ELISA (IgM) | 45 (8.8) | March 1998 | [11] |
Whole country | RT-PCR | 453 (3.5); DENV-1 (85.0); DENV-2 (15.0) | 2003–2012 | [10] |
Equateur (Health Zone Ingende), Sud-Ubangi (Gemena), Nord Ubangi (Health Zone Mobayi-mbongo, HZ Bili from Bosobolo) | RT-PCR | 110 (3.6) | 2003–2012 | [10] |
Bas-Uelé (Health Zones Titule, Lubunga) Tshopo (Makiso-Kisangani, Lubinga) | RT-PCR | 168 (4.7) | 2003–2012 | [10] |
Kasai Oriental (Health Zone Diulu in Mbujimayi) | RT-PCR | 51 (1.9) | 2003–2012 | [10] |
Kasai (Health Zone Kakenge from Mweka) | RT-PCR | 41 (2.4) | 2003–2012 | [10] |
Kongo-Central (Health Zones Kimpese, Kimpangu) | RT-PCR | 11 (18.1) | 2003–2012 | [10] |
Kinshasa (Binza-Meteo) | Rapid test NS1 | 111 (2.7) | 2012 | [16] |
Mongala (Bumba), Kasai Oriental, Kinshasa (Kingabwa) | ELISA, PRNT | 978 (3.8% in ELISA, of 32 ELISA (+) 9.4% (+) in PRNT) Serotypes: DENV-1, DENV-2, DENV-3 | 2013–2014 | [9] |
Kinshasa (Mbinza-Meteo) | Rapid test NS1, RT-PCR | 96 (3.0% in rapid test NS1; 1.0% in RT-PCR) | 2014 | [30] |
Rift Valley fever
Rift Valley Fever virus has been reported in humans and cattle in DRC. A low rate (4%) of IgG antibodies from human against RVFV was reported in 1998 from Kisangani in the north-eastern region [11]. In 2009, Mulumba et al. [34] reported a seroprevalence of 20% among cattle in Katanga in the southern region. In 2018, a seroprevalence (IgG and IgM) of 2–16% among cattle was reported in three provinces (Nord-Kivu, Sud-Kivu, Ituri) from the eastern region [35]. In 2014, RVFV was also detected by RT-PCR from a pool of Aedes mosquitoes collected around Ndjili River in Kinshasa [13].
Zika
Two studies on Zika were identified during the review. In the first study, of 453 archived sera collected country-wide from 2003–2011 that tested YFV negative were also negative for ZIKV virus using RT-PCR [10]. The second study analysed 978 blood samples collected during 2013–2014 showed that 34 samples (3.5%) were positive for Zika antibodies using ELISA. However, of the 34 samples that tested positive in ELISA, only one remained positive for ZIKV by PRNT [9]. This positive case of Zika was reported from the north-western part of DRC, from Sud-Ubangi Province bordering the Central African Republic.
West Nile virus
In the DRC, antibodies against WNV in humans have been detected by virus neutralization tests, first in 1942 in Buta, Ango and Bondo from Bas-Uélé Province located in the north-eastern part, and later in 1963 from Gemena in Sud-Ubangi in the north-western part [36, 37]. The seroprevalence in these areas varied greatly from 2% to 45%. In 1998, a high seroprevalence of WVN (66%) was reported, during a febrile illness outbreak following heavy rainfall in Kisangani [11]. But no WNV antibodies or RNA were detected in samples from Kinshasa collected during 1999–2000 during a CHIKV outbreak [28]. The specific neutralizing antibodies against WNV in Haut-Uelé Province have been detected in chimpanzee in Ango, Bondo [32], in buffalo and elephant in the Garamba National Park [35]. In a survey carried out in Kinshasa in 2004, nine (30%) out of 20 horses were WNV seropositive using ELISA and western blot analysis [38]. Afterwards, a 12.5% seroprevalence of WNV was reported in Kinshasa [39]. These observations provide evidence of an animal role in the enzootic circulation of WNV in the DRC.
O’nyong’nyong virus
O’nyong’nyong virus (ONNV) is a closer CHIKV related alphavirus vectored mainly by the Anopheles mosquito. Its RNA was detected by RT-PCR from a pool of Anopheles mosquito collected in Kinshasa [13]. Serological evidence of ONNV has been recorded in buffaloes from the Garamba National Park and duikers from the Ituri Rain Forest [33]. O’nyong’nyong outbreaks in humans were reported in neighbouring Uganda and Tanzania in 1996 [40]. However, no human case of ONNV infection has been reported in DRC.
Unspecified Flavivirus, Alphavirus and Bunyavirus
Significantly high rates of neutralizing antibodies against flaviviruses and alphaviruses have been reported in buffaloes, elephants, gorillas and duikers from the Congo River basin [33]. In Kinshasa, alphavirus and flavivirus RNA in mosquito pools have been amplified with the primers targeting a conserved region of these genera, but none of these mosquito pools have been amplified with specific primers for CHIKV, ONNV, YFV, WNV or DENV [13]. In the Ango and Bondo territories from Bas-Uélé, up to 100% of antibodies against bunyavirus in humans have been reported [32]. All these observations are likely to indicate the presence of several unidentified mosquito-borne viruses circulating in DRC. Therefore, further studies are needed to extend investigations about other mosquito-borne virus species instead of focusing only on well-known MBVs.
Mosquito vectors of arboviruses
Despite the medical and veterinary importance of mosquitoes, published reports on mosquito vectors of viruses are extremely rare in DRC. Entomological indices even during outbreaks within the regions with high mosquito-borne virus transmission risk are lacking in most cases. Moreover, Ae. aegypti and Ae. simpsoni were the most recorded in the regions where mosquito-borne virus outbreaks occurred. Yet, in certain areas, the presence of these Aedes species were not significantly recorded during outbreaks [41]. The entomological investigation during the first yellow fever outbreak at Matadi failed to collect a significant number of Ae. aegypti at that time [42]. Ten years later, Ae. aegypti predominated during the second yellow fever outbreak in Matadi and neighbouring townships [17], while in Gemena, Ae. simpsoni and Ae. aegypti were found in proportions of 90% and 10%, respectively during these outbreaks [18]. In the Bongo and Ango territories, where many mosquito-borne viruses reports are documented, Ae. aegypti predominated Ae. simpsoni [32]. In the four, last of the yellow fever outbreaks, Ae. aegypti larvae were collected from various breeding habitats in both natural and artificial breeding sites, while most positive breeding habitats were artificial [19–22]. A range of mosquitoes circulating in Kinshasa were found infected with different arboviruses [13]. O’nyong’nyong virus has been detected in Anopheles and unspecified flavivirus was detected in Culex mosquitoes (Table 3). Aedes albopictus has been recently established in Kinshasa [12], where the most recent outbreaks of chikungunya and dengue have been reported [16, 28, 30]; its implication in spreading mosquito-borne viruses in DRC needs to be investigated. It is important that vector species, distribution pattern, competence and virus infection rates are established. Furthermore, studies on the genetic population and vector competence will be more helpful in improving the understanding on transmission dynamics of mosquito-borne viruses in DRC.
Risk factors of mosquito-borne viral disease occurrence
Numerous factors might have contributed to the emergence and re-emergence of mosquito-borne viral infections in DRC. These driving factors range from demographic, socioeconomic, environmental to climatic factors. Moreover, evidence of population movement as key driving factor of spreading yellow fever has been documented [41]. High population density seems to play a key role in the occurrence and spread of mosquito-borne virus outbreaks [11, 41]. For instance, the WNV outbreak in Kisangani started at army camps where immigrated soldiers from different locations across the whole country were concentrated before it spread to another area [11]. In addition, the increase of animal and human population movements is very likely to be considered as important drivers of mosquito-borne viral infections in DRC [11, 41]. The human exposures to forest activities and deforestation activities in cities have been associated to the yellow fever outbreaks [18]. In addition, significant rates of antibodies against YFV have been detected among chimpanzee from savannah areas compared to those captured in forest areas [32]. In Gemena city, the yellow fever outbreaks have been observed during large deforestation activities [18]. The overall geographical distribution of both mosquito-borne viruses and their potential vectors species seemed to be influenced by climate distribution pattern in DRC. The majority of outbreaks or positive cases occurred during the rainy seasons. The West Nile outbreak was preceded by heavy rainfall in Kisangani in 1998 [11]. Similarly, in Kinshasa, in 1999–2000, the large chikungunya outbreak followed heavy rainfall [28].
Discussion
The overall findings indicate that mosquito-borne viral infections are an emerging and re-emerging health concern in the DRC. However, little attention has been paid and many questions on its epidemiology, socio-ecology and anthropology need to be addressed. While mosquito-borne viruses are re-emerging or emerging across the whole country, the north-western, north-eastern and western parts of the DRC are the most affected areas, experiencing multiple outbreaks compared to other parts of the country [9–11, 14, 15, 19–22]. This geographical distribution pattern of mosquito-borne viruses appeared to be linked to profile of the distribution, diversity and abundance of their potential vector species; most likely to be influenced by climate distribution pattern in DRC. In the eastern region, Ae. aegypti was rarely reported [43] compared to other regions [12, 44–48]. Indeed, the northern regions are experiencing an equatorial climate with rain throughout the year. From the central region to western region the climate is tropical with long rains, while in eastern and southern regions the climate is tropical but semi-arid. The Congo Basin has warmed between 0.2–0.3 °C per decade and reached 1 °C in 1992. The average annual precipitation has declined by 8–12% from 1960 to 1998. Climate change is manifested in DRC by short periods of heavy rainfall leading to multiple flooding events followed by early droughts [49, 50]. This considerable fluctuation in the climate regime causing either drought or flooding has an influence on vector abundance and diversity [51]. Most probably, heavy rainfalls are creating suitable mosquito breeding habitats, hence transmission of mosquito-borne viruses. Nevertheless, due to climate variability and increasing population movements, these mosquito species might establish successfully over time and change this general trend. Although, there is evidence of ZIKV, DENV and RVFV circulation in DRC, no epidemic has been reported so far.
This review indicates that there is a dearth of information as regards to vector and transmission indices of mosquito-borne viral infections in DRC. This underlines the importance of better identification of different local vectors in each region or specific area within regions, and to assess competence of the vectors to transmit mosquito-borne viruses. Intensive deforestation activities in Gemena city provided an opportunity for mosquito-borne viruses to emerge [18]. It is likely because of the degradation of the forest habitats during these activities, Aedes mosquitoes invaded the city and successfully established in their new habitats closer to humans, leading to a high human mosquito biting rate in a deforested area. Indeed, the increased carbon dioxide in the atmosphere due to deforestation warms up the climate and causes changes in rainfall patterns leading to conditions of flood or drought. The establishment of new suitable habitats is creating an opportunity for new mosquito species to proliferate [52]. This is in corroboration with observations from Brazil, where deforestation has been involved in sylvatic yellow fever outbreaks [53]. It was reported that mosquitoes which are known to be zoophilic and sylvatic have invaded the peridomestic and periurban settlements and started to feed on humans [53]. Similar observations from the Ivory Coast illustrated the impact of land-use modifications on the abundance, distribution, and host-seeking behaviour of Aedes mosquitoes [54]. A study in the Amazon concluded that deforestation is responsible for the increase in malaria incidence [55]. This observation could emphasize the impact of significant deforestation observed across the DRC in relation to the emergence of mosquito-borne viral diseases and repeated outbreaks in the country. There is currently a need to investigate the impact of environmental factors and the role of climate change on current mosquito-borne virus geographical distribution and predicting potential distribution in the future.
Climate change influences the frequency of mosquito-borne disease occurrence by affecting host and vector diversity, abundance, genetics and the pathogen infection load in the host and vector. Climate affects growth, survival and abundance of the vectors and virus replication load in the vector. Temperature is the major climate component susceptible to accelerate or decelerate mosquito reproduction and virus replication in the host depending on low and high temperature thresholds. Increased levels of precipitation lead to multiple microhabitats for oviposition and an efficient larval development pattern [51]. The higher rainfall levels due to climate change were associated with RFV outbreaks in eastern Africa during 2015–2016 [56].
RVFV is remarkably distributed in the eastern region of the DRC starting from the South to the North extremity. This region constitutes long borders with Zambia, Tanzania, Burundi, Rwanda, Uganda and South Sudan. Most of these countries are known to be endemic of Rift Valley fever [56–60]. It is likely that the active and uncontrolled migration of human and animal population might have played a key role in spreading of RVFV in the DRC. Considering the largest cattle population in eastern DRC, the situation represents a real health threat that needs more attention. The role of population movement in the emergence and spread of mosquito-borne viruses have been illustrated in a recent study of a yellow fever outbreak which started in Angola and was imported to the DRC through trans-boundary trade between the two countries [41]. Environmental and climate factors, human activities and population movement are likely contributing enormously to the emergence and re-emergence of mosquito-borne viruses. An exponential demographic growth of Kinshasa with poor environmental hygiene and low urbanisation level is likely to have favoured Aedes mosquito productivity and might explain in part the frequent chikungunya and yellow fever outbreaks in the city.
Conclusions
Despite the limited information on mosquito-borne viruses and their vectors in DRC, available evidence indicates the wide-range of mosquito-borne virus species, potential hosts and vector species occurring in the country. The diversity of mosquito-borne viruses is underestimated, as well the current mosquito-borne viral disease burden and its driving factors. The tendency is that the continuous geographical expansion of mosquito-borne viruses leads to fears that multiple epidemic outbreaks are likely to arise in the DRC. There is a dearth of information on mosquitoes, in particular Aedes, which is known to be the main vector of major mosquito-borne viruses. The lack of information is a barrier to appropriate knowledge on the ecology and epidemiology of mosquito-borne viruses, which is crucial in the design of appropriate interventions. Evidence for circulation of mosquito-borne viruses in livestock and domestic animals from the DRC, and the increasing mosquito-borne virus distribution over time and space, call for robust holistic mosquito-borne virus surveillance systems, including One Health approaches with emphasis on integrated vector control.
Acknowledgements
The authors are grateful to the OSFAC team for geographical data.
Abbreviations
- CHIKV
chikungunya virus
- DENV
dengue virus
- RVFV
Rift Valley fever virus
- YFV
yellow fever virus
- WNV
West Nile virus
- ZIKV
Zika virus
- DRC
Democratic Republic of the Congo
- ELISA
enzyme‐linked immunosorbent assay
- PRNT
plaque reduction neutralization test
- RT-PCR
reverse transcription polymerase chain reaction
Authors’ contributions
KMM designed the study, searched articles for reviewing and prepared the manuscript for publication. LM searched articles, read and critically revised the manuscript for publication. RW searched articles for reviewing and read the manuscript for publication. FKL searched articles, participated in developing the maps, critically read the manuscript for publication. GM read critically the manuscript for publication. SK participated in the study design, searched articles for reviewing. All authors read and approved the final manuscript.
Funding
KMM is a graduate student supported by a scholarship from the Government of Tanzania funding through a World Bank WB-ACE II Grant PAD1436 to SACIDS Africa Centre of Excellence for Infectious Diseases of Humans and Animals in Southern and Eastern Africa (SACIDS-ACE).
Availability of data and materials
The datasets supporting the conclusions of this article are included within the article.
Ethics approval and consent to participate
Not applicable.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Footnotes
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Contributor Information
Kennedy M. Mbanzulu, Email: mbanzulu.kennedy@sacids.org
Leonard E. G. Mboera, Email: lmboera@gmail.com
Flory K. Luzolo, Email: luzolokhote@gmail.com
Roger Wumba, Email: rogerwumba@gmail.com.
Gerald Misinzo, Email: gerald.misinzo@sacids.org.
Sharadhuli I. Kimera, Email: sikimera@sua.ac.tz
References
- 1.Gubler DJ. The global emergence/resurgence of arboviral diseases as public health problems. Arch Med Res. 2002;33:330–342. doi: 10.1016/S0188-4409(02)00378-8. [DOI] [PubMed] [Google Scholar]
- 2.Smith KM, Nanda K, Spears CJ, Ribeiro M, Vancini R, Piper A, et al. Structural mutants of dengue virus 2 transmembrane domains exhibit host-range phenotype. Virol J. 2011;8:289. doi: 10.1186/1743-422X-8-289. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Reiter P. Climate change and mosquito-borne disease. Environ Health Perspect. 2001;109:141–161. doi: 10.1289/ehp.01109s1141. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Weetman D, Kamgang B, Badolo A, Moyes CL, Shearer FM, Coulibaly M, et al. Aedes mosquitoes and Aedes-borne arboviruses in Africa: current and future threats. Int J Environ Res Public Health. 2018;15:220. doi: 10.3390/ijerph15020220. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Kajeguka D, Kaaya R, Mwakalinga S, Ndossi R, Ndaro A, Chilongola JO, et al. Prevalence of dengue and chikungunya virus infections in north-eastern Tanzania: a cross sectional study among participants presenting with malaria-like symptoms. BMC Infect Dis. 2016;16:183. doi: 10.1186/s12879-016-1511-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Carrillo-Hernández MY, Ruiz-Saenz J, Villamizar LJ, Gómez-Rangel SY, Martínez-Gutierrez M. Co-circulation and simultaneous co-infection of dengue, chikungunya, and Zika viruses in patients with febrile syndrome at the Colombian-Venezuelan border. BMC Infect Dis. 2018;18:61. doi: 10.1186/s12879-018-2976-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Deprez GA. Case of yellow fever at Matadi (Belgian Congo) in 1917. Ann Soc Belg Med Trop. 1920;1:61–68. [Google Scholar]
- 8.Brès P. Données récentes apportées par les enquêtes sérologiques sur la prévalence des arbovirus en Afrique, avec référence spéciale à la fièvre jaune. Bull World Health Org. 1973;43:223–267. [PMC free article] [PubMed] [Google Scholar]
- 9.Willcox AC, Collins MH, Jadi R, Keeler C, Parr JB, Mumba D, et al. Seroepidemiology of dengue, Zika, and yellow fever viruses among children in the Democratic Republic of the Congo. Am J Trop Med Hyg. 2018;99:756–763. doi: 10.4269/ajtmh.18-0156. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Makiala-Mandanda S, Ahuka-Mundeke S, Abbate JL, Pukuta-Simbu E, Nsio-Mbeta J, Berthet N, et al. Identification of dengue and chikungunya cases among suspected cases of yellow fever in the Democratic Republic of the Congo. Vector Borne Zoonotic Dis. 2018;18:364–370. doi: 10.1089/vbz.2017.2176. [DOI] [PubMed] [Google Scholar]
- 11.Nur YA, Groen J, Heuvelmans H, Tuynman W, Copra C, Osterhaus AD. An outbreak of West Nile fever among migrants in Kisangani, Democratic Republic of Congo. Am J Trop Med Hyg. 1999;61:885–888. doi: 10.4269/ajtmh.1999.61.885. [DOI] [PubMed] [Google Scholar]
- 12.Bobanga T, Moyo M, Vulu F, Irish S. First report of Aedes albopictus (Diptera: Culicidae) in the Democratic Republic of Congo. Afr Entomol. 2018;26:234–236. doi: 10.4001/003.026.0234. [DOI] [Google Scholar]
- 13.Mbanzulu KM, Wumba R, Mukendi JK, Zanga JK, Shija F, Bobanga TL, et al. Mosquito-borne viruses circulating in Kinshasa, Democratic Republic of the Congo. Int J Infect Dis. 2017;57:32–37. doi: 10.1016/j.ijid.2017.01.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Osterrieth P, Blanes-Ridaura G. Recherches sur le virus de chikungunya au Congo, isolément du virus dans le Haut-Uélé. Ann Soc Belge Méd Trop. 1960;4:199–203. [PubMed] [Google Scholar]
- 15.Osterrieth P, Rathé E, Deleplanque-Liegeois P. Isolément simultané des virus de la fièvre jaune et de chikungunya à Bili (Haut-Uélé, Congo Belge) Ann Soc Belge Méd Trop. 1961;3:207–212. [PubMed] [Google Scholar]
- 16.Malekani MJ, Mccollum AM, Monroe B, Malekani V, Mulumba M, Nguete B, Karhemere SR. Cas de dengue chez les patients suspects de chikungunya à Kinshasa. Ann Afr Med. 2014;7:2. [Google Scholar]
- 17.Mouchet R. Rapport sur l’épidémie de la fièvre jaune. Ann Soc Belge Méd Trop. 1928;8:219–232. [Google Scholar]
- 18.Courtois G, Osterrieth P. A propos de l’épidemie de la fièvre jaune à Gemena. Ann Soc Belge Méd Trop. 1962;6:859–864. [PubMed] [Google Scholar]
- 19.WHO. Yellow fever in the Democratic Republic of the Congo. Geneva: World Health Organisation; 2010. http://www.who.int/csr/don/2010_07_19a/. Accessed 13 Nov 2018.
- 20.WHO. Yellow fever in the Democratic Republic of Congo. Geneva: World Health Organisation; 2013. http://www.who.int/csr/don/2013_06_14_yellowfever/en/. Accessed 13 Nov 2018.
- 21.WHO. Yellow fever Democratic Republic of the Congo. Geneva: World Health Organisation; 2014. http://www.who.int/csr/don/02-june-2014-yellow-fever-drc/en/. Accessed 13 Nov 2018.
- 22.WHO. Situation report yellow fever. Geneva: World Health Organisation; 2016. http://apps.who.int/iris/bitstream/10665/250661/1/yellowfeversitrep28Oct16-eng.pdf?ua=1. Accessed 12 Dec 2019.
- 23.Otshudiema JO, Ndakala NG, Mawanda EK, Tshapenda GP, Kimfuta JM, Nsibu LN, et al. Yellow fever outbreak Kongo Central province. Democratic Republic of the Congo. MMWR. 2017;66:335–338. doi: 10.15585/mmwr.mm6612a5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.WHO. Mapping the risk and distribution of epidemics in the WHO African region a technical report. Geneva: World Health Organisation; 2016. http://apps.who.int/iris/bitstream/10665/206560/1/97892902330844. Accessed 13 Nov 2018.
- 25.Liegeois P, Rousseau Courtois G. Complément d’enquête sur la distribution l’immunité antiamarile naturelle chez les indigènes du Congo belge. Ann soc Belge Méd Trop. 1948;28:247. [PubMed] [Google Scholar]
- 26.Van Der Bergher L. Sur existence d’une immunité amarile récente chez des enfants dans les Bas-congo. Ann Soc Belge Méd Trop. 1937;4:581. [Google Scholar]
- 27.Van Den Berghe L. Yellow fever immunity in sera from cases of jaundice in Uélé (Welle), Belgian Congo. Ann Soc Belg Med Trop. 1935;15:4. [Google Scholar]
- 28.Muyembe-Tamfum JJ, Peyrefitte CN, Yogolelo R, Basisya ME, Koyange D, Pukuta E, et al. Epidemic of chikungunya virus in 1999 and 2000 in the Democratic Republic of the Congo. Med Trop Rev Corps Sante Colon. 2003;63:637–638. [PubMed] [Google Scholar]
- 29.Bossche VD, Cnops L, Meersman K, Domingo C, Gompel VA, Esbroeck VM. Chikungunya virus and West Nile virus infections imported into Belgium, 2007–2012. Epidemiol Infect. 2015;143:2227–2236. doi: 10.1017/S0950268814000685. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Ido E, Ahuka S, Karhemere S, Shibata K, Kameoka M, Muyembe JJ. Infection du virus de la dengue survenue lors d’une épidémie du virus chikungunya en République démocratique du Congo. Ann Afr Med. 2017;10:1. https://anafrimed.net/. Accessed 13 Nov 2018.
- 31.Pastorino B, Muyembe-Tamfum JJ, Bessaud M, Tock F, Tolou H, Durand JP, et al. Epidemic resurgence of chikungunya virus in Democratic Republic of the Congo: identification of a new central African strain. J Med Virol. 2004;74:277–282. doi: 10.1002/jmv.20168. [DOI] [PubMed] [Google Scholar]
- 32.Osterrieth P, Deleplanque-Liegeois P. Présence d’anticorps vis-à-vis de virus transmis par les arthropodes chez le chimpanzé (Pan tronglodites), comparaison de leur état immunitaire à celui de l’homme. Ann Soc Belge Méd Trop. 1961;1:63–72. [PubMed] [Google Scholar]
- 33.Kading RC, Borland EM, Cranfield M, Powers AM. Prevalence of antibodies to alphaviruses and flaviviruses in free-ranging game animals and nonhuman primates in the greater Congo basin. J Wildl Dis. 2013;49:587–599. doi: 10.7589/2012-08-212. [DOI] [PubMed] [Google Scholar]
- 34.Tshilenge G. Immunogeno: protective mechanism for Rift valley fever in the Democratic Republic of Congo. J Vet Res. 2012;79:1. [Google Scholar]
- 35.Georges TM, Justin M, Victor M, Marie KJ, Mark R, Léopold MMK. Seroprevalence and virus activity of Rift valley fever in cattle in eastern region of Democratic Republic of the Congo. J Vet Med. 2018;2018:4956378. doi: 10.1155/2018/4956378. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Smithburn K, Jacob HR. Neutralisation-tests against neurotropic viruses with sera collected in central Africa. Trans R Soc Trop Med Hyg. 1942;36:9–20. doi: 10.1016/S0035-9203(42)90051-8. [DOI] [Google Scholar]
- 37.Lucasse C. First isolation of West Nile virus in central Africa. Bull Soc Path Ex. 1961;56:156–161. [PubMed] [Google Scholar]
- 38.Cabre O, Grandadam M, Marié JL, Gravier P, Prangé A, Santinelli Y, et al. West Nile virus in horses, sub-Saharan Africa. Emerg Infect Dis. 2006;12:1958–1960. doi: 10.3201/eid1212.060042. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Davoust B, Leparc-Goffart I, Demoncheaux JP, Tine R, Diarra M, Trombini G, et al. Serologic surveillance for West Nile virus in dogs. Africa. Emerg Infect Dis. 2014;20:1415–1417. doi: 10.3201/eid2008.130691. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Rwaguma E, Lutwama J, Sempala S, Kiwanuka N, Kamugisha J, Okware S, et al. Emergence of epidemic oʼnyong-nyong fever in southwestern Uganda, after an absence of 35 years. Emerg Infect Dis. 1997;3:77. doi: 10.3201/eid0301.970112. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Kraemer MUG, Faria NR, Reiner RC, Golding JN, Nikolay B, Stasse S, et al. Spread of yellow fever virus outbreak in Angola and the Democratic Republic of the Congo 2015–16: a modelling study. Lancet Infect Dis. 2017;17:330. doi: 10.1016/S1473-3099(16)30513-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Seidelin H. Notes sur la prophylaxie et le traitement de la fièvre jaune au Congo. http://lib.itg.be/open/asbmt/1921/1921asbm0231.pdf. Accessed 13 Nov 2018.
- 43.Schwetz J. Contribution à l’étude des anophélines du Congo oriental (Lac Kivu-Lac Albert) Ann Soc Belge Méd Trop. 1941;21:17–36. [Google Scholar]
- 44.Fain A, Henrard C. Quelques moustiques du fleuve Congo (Chenal) et des riviéres Kasai et Kwango. Ann Soc Belge Méd Trop. 1948;28:7–20. [PubMed] [Google Scholar]
- 45.Schwetz J. Contribution à l’étude des moustiques de quelques localités du Bas-Congo. Ann Soc Belge Méd Trop. 1938;18:89–113. [Google Scholar]
- 46.Schwetz J. Contribution à l’étude des moustiques d’Elisabethville et de quelques autres localités du Katanga (Congo belge) Bull Soc Path Ex. 1927;20:170–192. [Google Scholar]
- 47.Schwetz J. Notes geographiques d’entomologie medicale sur la Province Orientale (Congo Belge) Ann Soc Belge Méd Trop. 1932;12:549–555. [Google Scholar]
- 48.Karch S, AsidiI N, Manzambi Z, Salaun JJ. La faune culicidiene et sa nuissance à Kinshasa (Zaire) Bull Soc Path Ex. 1993;86:68–75. [PubMed] [Google Scholar]
- 49.United Nations Framework Convention on Climate Change. Democratic Republic of Congo, second national communication on Climate change and human health in DRC. UNFCCC; 2009. https://unfccc.int/resource/docs/natc/rdcnc2exsume.pdf. Accessed 10 Dec 2019.
- 50.Tshiabukole K, Khonde P, Muku M, Vumilia K, Lunekua K, Kankolongo M, et al. Influence of climate variability on seasonal rainfall patterns in south-western DR Congo. OALibJ. 2016;3:e2952. [Google Scholar]
- 51.Mills JN, Gage KL, Khan AS. Potential Influence of climate change on vector-borne and zoonotic diseases: a review and proposed research plan. Environ Health Perspect. 2010;118:1507–1514. doi: 10.1289/ehp.0901389. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Alarcón-Elbal PM. Deforestation and mosquito-borne diseases: another ‛wake-up callʼ to Latin America. Inter Am J Med Health. 2018;1:e201801003. [Google Scholar]
- 53.Vasconcelos PF, Travassos da Rosa AP, Rodrigues SG, Travassos da Rosa ES, Dégallier N, Travassos da Rosa JF. Inadequate management of natural ecosystem in the Brazilian Amazon region results in the emergence and re-emergence of arboviruses. Cad Saude Publica. 2001;17:155–164. doi: 10.1590/S0102-311X2001000700025. [DOI] [PubMed] [Google Scholar]
- 54.Zahouili JBZ, Koudou BG, Muller P, Malone D, Tano Y, Utzinger J. Effect of land-use changes on the abundance, distribution, and host-seeking behaviour of Aedes arbovirus vectors in oil palm-dominated landscapes, Southeastern Cote d’Ivoire. PLoS ONE. 2017;7:12. doi: 10.1371/journal.pone.0189082. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Chaves LSM, Conn JE, López RVM, Sallum MAM. Abundance of impacted forest patches less than 5 km2 is a key driver of the incidence of malaria in Amazonian Brazil. Sci Rep. 2018;8:7077. doi: 10.1038/s41598-018-25344-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Oyas H, Holmstrom L, Kemunto NP, Muturi M, Mwatondo A, Osoro E, Bitek A, et al. Enhanced surveillance for Rift Valley fever in livestock during El Niño rains and threat of RVF outbreak, Kenya, 2015–2016. PLoS Negl Trop Dis. 2018;12:e0006353. doi: 10.1371/journal.pntd.0006353. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Umuhoza T, Berkvens D, Gafarasi I, Rukelibuga J, Mushonga B, Biryomumaisho S. Seroprevalence of Rift valley fever in cattle along the Akagera-Nyabarongo rivers, Rwanda. J S Afr Vet Assoc. 2017;88:1379. doi: 10.4102/jsava.v88i0.1379. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Davies FG, Kilelu E, Linthicum KJ, Pegram RG. Patterns of Rift Valley fever activity in Zambia. Epidemiol Infect. 1992;108:185–191. doi: 10.1017/S0950268800049633. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Matiko MK, Salekwa LP, Kasanga CJ, Kimera SI, Evander M, Nyangi WP. Serological evidence of inter-epizootic circulation of Rift valley fever virus in domestic cattle in Kyela and Morogoro. Tanzania. PLoS Negl Trop Dis. 2018;12:e0006931. doi: 10.1371/journal.pntd.0006931. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Nyakarahuka L, de St Maurice A, Purpura L, Ervin E, Balinandi S, Tumusime A, Kyondo J, et al. Prevalence and risk factors of Rift Valley fever in humans and animals from Kabale district in southwestern Uganda. PLoS Negl Trop Dis. 2016;2:e0006412. doi: 10.1371/journal.pntd.0006412. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
The datasets supporting the conclusions of this article are included within the article.